Physician profile
Mark A Blum
NPI 1134216526
$40,503.79
in general payments reported to CMS, 2019-2025
46 companies · $1,642 in 2025
The $1,642 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $10K · 2021: $2,613 · 2022: $5,783 · 2023: $2,263 · 2024: $2,024 · 2025: $1,642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,929.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $21,325.23 | 2019-2024 | Xarelto |
| Amgen INC. | $7,809.40 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $1,212.85 | 2019-2025 | |
| Boston Scientific Corporation | $1,062.29 | 2019-2025 | Watchman Flx, Watchman Access System, Watchman |
| Boehringer Ingelheim Pharmaceuticals, INC. | $938.39 | 2019-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $807.65 | 2019-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $724.54 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $626.97 | 2021-2025 | Verquvo, Capvaxive |
| Amarin Pharma, INC. | $599.00 | 2019-2023 | |
| Baxter Healthcare | $497.22 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Arbor Pharmaceuticals, INC. | $493.45 | 2019-2021 | |
| Novo Nordisk INC | $490.77 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $342.79 | 2022-2025 | |
| Alnylam Pharmaceuticals INC. | $314.22 | 2020-2025 | Onpattro |
| Kowa Pharmaceuticals America, INC. | $302.42 | 2019-2024 | Livalo |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $294.97 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Kestra Medical Technology Services, INC. | $241.46 | 2022-2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $222.49 | 2019-2025 | Farxiga |
| Esperion Therapeutics, INC. | $210.92 | 2021-2025 | Nexletol |
| Regeneron Healthcare Solutions, INC. | $194.12 | 2019-2023 | Evkeeza |
| E.R. Squibb & Sons, L.L.C. | $183.47 | 2019-2024 | Camzyos |
| Abbott Laboratories | $180.01 | 2020-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Cvrx, INC. | $163.86 | 2024-2025 | Barostim Neo System |
| Heartflow, INC. | $147.47 | 2022-2025 | Ffrct |
| Scpharmaceuticals INC. | $147.29 | 2023-2025 | |
| Kiniksa Pharmaceuticals, LTD. | $101.38 | 2022-2023 | Arcalyst |
| Philips North America LLC | $98.19 | 2024-2025 | (5044) Mcot, Extended Holter |
| Althera Pharmaceuticals LLC | $97.40 | 2021-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $93.63 | 2024 | Arcalyst |
| Bardy Diagnostics, INC. | $90.33 | 2019-2021 | |
| Impulse Dynamics (USA) INC. | $89.44 | 2023-2024 | Optimizer, Optimizer |
| Biosense Webster, INC. | $82.77 | 2019-2023 | Carto 3 |
| Azurity Pharmaceuticals, INC. | $48.47 | 2024-2025 | Edarbyclor, Edarbi |
| Lundbeck LLC | $46.62 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.27 | 2021-2025 | |
| Medicure Pharma INC. | $26.62 | 2021 | |
| Lilly USA, LLC | $19.13 | 2025 | Zepbound |
| Atricure, INC. | $18.76 | 2021 | |
| Bridgebio Pharma, INC. | $18.46 | 2025 | Attruby |
| Genzyme Corporation | $16.99 | 2023 | |
| Abiomed | $16.39 | 2019 | |
| Ionis Pharmaceuticals, INC. | $16.38 | 2025 | Tryngolza |
| Daiichi Sankyo INC. | $16.24 | 2019 | |
| Glaxosmithkline, LLC. | $15.45 | 2025 | Arexvy, Shingrix |
| Amryt Pharma Holdings LTD | $13.33 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $13.29 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Blum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.